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INTRODUCTION: Honey is a common household product with many medicinal uses described in traditional
medicine. Only recently has its antioxidant properties and preventive effects against disease been highlighted.
Chrysin is a natural flavone commonly found in honey that has been shown to be an antioxidant agent. In this study,
we investigated the antiproliferative and apoptotic effects of honey and chrysin on cultured human prostate cancer
cells.
METHODS: Cells were cultured in RPMI medium and treated with different concentrations of honey and chrysin for
three consecutive days. Cell viability was quantitated by the 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium
bromide (MTT) assay. The percentage of apoptotic cells was determined by flow cytometry using Annexin V-
fluorescein isothiocyanate.
RESULTS: The MTT assay revealed that both compounds had an antiproliferative effect on PC-3 cells in a dose- and
time-dependent manner. The IC50 values for honey and chrysin against PC-3 cells were 2.5% and 24.5% after 48 h
and 1.8% and 8.5% after 72 h, respectively. Chrysin induced apoptosis in PC-3 cells, as determined by flow
cytometry.
CONCLUSION: Our results suggest that honey has anti-proliferative effects on prostate cancer cells and the effects
are mainly due to chrysin. Therefore, chrysin may be a potential compound for both cancer prevention and
treatment. Further in vivo investigation is needed to support the use of chrysin in cancer therapy.
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INTRODUCTION
Prostate cancer is the second most prevalent malignancy
and the second leading cause of cancer-related deaths
among men in the United States, with similar trends in
many western countries.
1 Prostate cancer is usually diag-
nosed in men over 50 years of age and with life expectancy
increasing worldwide the incidence of prostate cancer is
also likely to increase.
1,2 The fine balance between cell
proliferation and apoptotic death is lost in cancer, con-
tributing to increased cellular mass and tumor progression.
In terms of prostate cancer chemoprevention, there is
considerable emphasis on identifying novel natural pro-
ducts that selectively induce apoptosis and growth arrest in
prostate cancer cells without cytotoxic effects in normal
cells.
3,4
Foods rich in antioxidants have preventive effects against
cancer, coronary disease, inflammatory disorders, and
neurological degeneration.
5,6 One such food includes
honey,
7,8 which has been used as a traditional food source
since ancient times. Honey is made when nectar and sweet
deposits from plants are gathered, modified, and stored in a
honeycomb by honeybees. Its major components are
fructose and glucose and it also consists of carbohydrates,
proteins, amino acids, vitamins, water, minerals, and
enzymes. Honey exhibits a broad spectrum of therapeutic
properties, including antibacterial, antifungal, cytostatic,
9,10
wound healing,
11 and anti-inflammatory activities.
12 There
are also many reports in the medical literature of honey
being effective as a dressing for wounds,
13,14 burns,
15-17 and
ulcers.
18,19 Honey has been to treat Fournier’s gangrene,
abdominal wound disruption, gastric ulcers,
20 gastroenter-
itis, and burns and to store skin grafts.
21 Honey seems to
have no harmful effects and actually enables faster healing
of wounds by promoting the formation of new tissues.
It was recently shown that honey could induce apoptosis
in T24, RT4, 253J, and MBT-2 bladder cancer cell lines. In
addition, honey significantly inhibition proliferation in T24
and MBT-2 cell lines by 1-25% and in RT4 and 253J cell lines
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1073by 6-25%.
22 Honey possesses moderate antitumor and
pronounced antimetastatic effects, as demonstrated in five
different strains of tumors in rat and mouse models.
23
Some minor constituents of honey are believed to have
antioxidant properties,
24 including flavonoids and phenolic
acids,
25,26 certain enzymes (glucose oxidase, catalase),
ascorbic acid,
27 carotenoid-like substances,
28 amino acids,
and proteins.
29 Therefore, it is possible that the antitumor
properties of honey are attributable to its polyphenols. With
the evolution of extraction procedures for various poly-
phenols, it is possible to concentrate and study the
polyphenolic compounds extracted from honey rather than
crude honey itself.
Phenolic compounds, or polyphenols, are an important
group of compounds that occur in plants and comprise at
least 8,000 different known structures.
30 They are also
produced by plants as secondary metabolites and are
present in honey. Phenolic compounds can be divided into
at least 10 different types based upon their structure: simple
phenols, phenolic acids, coumarins, isocoumarins, naphtho-
quinones, xanthones, stilbenes, anthaquinones, flavonoids,
and lignins. Flavonoids are the most important polyphe-
nolic class, with more than 5,000 compounds already
described. Flavonoids are natural antioxidants that exhibit
a wide range of biological effects, including antibacterial,
anti-inflammatory, antiallergic, antithrombotic, and vasodi-
latory actions.
31 Chrysin (5,7-dihydroxyflavone) is a natural
and biologically active flavone extracted from honey, plants,
and propolis. It has potent anti-inflammatory and antiox-
idant properties and promotes cell death by perturbing cell
cycle progression.
Since honey is a common food for humans, we investi-
gated whether it is a potential candidate for prostate cancer
treatment by analyzing the cytotoxic and apoptotic effects of
it and one of its phenolic compounds, chrysin, on prostate
cancer cell lines.
MATERIAL AND METHODS
Chemicals and reagents
MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazo-
lium bromide) was purchased from Amerso (USA). RPMI
1640 was purchased from Gibco BRL (Grand Island, NY,
USA). Annexin V/FITC (fluorescein isothiocyanate) was
obtained from Invitrogen Corporation (USA). Fetal bovine
serum was purchased from PAA Laboratories GmbH,
Austria. Chrysin (5,7-dihydroxyflavone), was purchased
from Sigma-Aldrich (St. Louis, MO).
Cell culture
The human prostate cancer cell line PC-3 was obtained
from the Pasteur Institute of Iran and cultured in RPMI
medium supplemented with 10% FBS, 100 U/ml penicillin,
and 100 mg/ml streptomycin. PC-3 cells were cultured in a
CO2 incubator (MCO-17AI, Sanyo Electric Co., Ltd., Japan)
at 37˚C in a humidified atmosphere enriched by 5% CO2 and
subcultured every 3–4 days.
Cell viability assay
Cell viability was measured using the MTT assay, which
is based on the conversion of MTT to formazan crystals by
mitochondrial dehydrogenases. Briefly, PC-3 cells were
plated at a density of 1610
3 cells/ml in 96-well plates and
allowed to attach for 24 h, resulting in log phase growth at
the time of drug treatment. Honey (2.5, 5, 10, and 20%) and
chrysin (10, 20, 30, and 40 mM) were added to the wells for
24, 48, and 72 hours. After treatment, 10 ml MTT was added
to each well. After 4 h of incubation at 37˚C, the solution was
removed and the produced formazan was solubilized in
100 ml of dimethyl sulfoxide (DMSO). Absorbance was
measured at 550 nm using an automated microplate reader
(Bio-Rad 550). Cell viability was expressed as a percentage
of the value for control cultures. The cytotoxic effects of
honey and chrysin on PC-3 were expressed as IC50 values
(the drug concentration that reduced the absorbance of
treated cells by 50% compared to untreated cells). All
experiments were carried out in triplicate.
Morphological studies
Morphological changes consistent with cell death were
observed by using a normal inverted microscope. Cells were
treated for 48 h with chrysin (10 and 40 mM). Untreated cells
were used for a negative control. The morphological
changes of the cells were observed 48 h post-treatment.
Assessment of apoptosis by Annexin V-FITC
Apoptotic cell death was measured using a flouresin
isothiocynate (FITC)-conjugated Annexin V/PI assay kit by
flow cytometry. Briefly, 5610
5 cells were washed with ice–
cold PBS, resuspended in 100 ml binding buffer, and stained
with 5 ml of FITC- conjugated Annexin V (10 mg/ml) and
10 ml of PI (50 mg/ml). The cells were incubated for 15 min
at room temperature in the dark, 400 ml of binding buffer
was added, and the cells were analyzed (FACScan, Becton-
Dickinson, USA). The PC-3 cells were gated separately
according to their granularity and size on forward scatter
(FSC) versus Side Scatter (SSC) plots. Early and late
apoptosis was evaluated on fluorescence 2 (FL2 for
propidium iodide) versus fluorescence 1 (FL1 for Annexin)
plots. Cells stained with only annexin V were evaluated as
being in early apoptosis; cells stained with both annexin V
and propidium iodide were evaluated as being in late
apoptosis or in a necrotic stage.
Statistical analysis
All results were expressed as mean ¡ SEM. Significance
was evaluated using ANOVA and Bonferroni’s test. A
probability level of p,0.05 was considered statistically
significant.
RESULTS
Effects of honey on cell viability
PC-3 cells were incubated with various concentrations of
honey for 24, 48, and 72 h. The impact of honey on cell
viability was quantitated 48 h post-exposure by the MTT
assay. Exposure of PC-3 cells to honey significantly
inhibited growth in a dose- and time-dependent manner
(p,0.001). While there was no significant effect from the
low concentration of honey after 24 hours (2.5%), there were
significant decreases in viability at concentrations of 5%,
10%, and 20% (p,0.05, p,0.01, and p,0.001, respectively,
Fig. 1). Treatment of PC-3 cells for 48 and 72 h resulted in
significant reductions in the number of viable cells at all
doses (2.5, 5, 10, and 20%, p,0.001, Fig. 1). The IC50 dose for
PC-3 cells was determined to be 2.5¡0.02% and 1.8¡0.03%
at 48 and 72 h, respectively (Table 1).
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The PC-3 carcinoma cell line was incubated with various
concentrations of chrysin for 24, 48, and 72 h. The
cytotoxicity of chrysin on cell viability was quantitated by
MTT assay. After 24 h of exposure to chrysin, significant
inhibitory effects on proliferation were only observed for the
highest concentration (40 mM, p,0.05). However, there
were significant decreases in viability for the concentrations
of 10, 20, 30, and 40 mM after 48 and 72 h (p,0.001, Fig. 2).
The IC50 dose was determined to be 24.5¡0.08 mM and
8.5¡0.01 mM at 48 and 72 h, respectively (Table 2).
Morphological evaluation
Although there were no significant morphological
changes after 24 h of incubation with the low dose of
chrysin (10 mM, data not shown), there were significant
changes after 48 h of incubation with concentrations of 10
and 40 mM of chrysin (Fig. 3). Cells treated with chrysin
(40 mM) showed more prominent growth inhibition and cell
shrinkage compared to cells treated with the lower dose of
chrysin (10 mM), consistent with the MTT results (Fig. 3).
Quantification of apoptosis by chrysin
PC-3 cells were treated with 10 and 40 mM chrysin for 48 h
to determine whether chrysin induced apoptosis. After
treatment, the cells were harvested and apoptosis was
examined by flow cytometry (Fig. 4). Quantitative analysis
using the Annexin V/PI assay showed that the proportion
of early stage apoptotic cells (Annexin V+/PI-) increased
significantly from 1.6% to 28.32% and the proportion of late
stage apoptotic cells (Annexin V+/PI+) increased signifi-
cantly from 1.5% to 36.7% (Fig. 5). Apoptosis induced by 10
and 40 mM of chrysin was significantly greater than in
untreated cells and the percentage of early and late
apoptotic cells significantly increased with chrysin concen-
tration (p,0.001).
DISCUSSION
In recent years, considerable efforts have been made to
identify naturally occurring compounds and related syn-
thetic agents that can prevent the development and
recurrence of cancer. Several naturally occurring com-
pounds, such as phenols, indoles, inositol-6-phosphate,
aromatic isothiocyanates, and dithiolethiones, have been
shown to inhibit several types of cancer. In addition, a wide
variety of natural food and food products can induce
apoptosis in various tumor cells. There is strong evidence
supporting the positive role of some natural materials and
medicinal plants in oncology and their ability affect all
phases of the tumorigenic process.
32 Therefore, it is
important to screen natural products, either as crude
extracts or as isolated components, for apoptotic properties
to identify potential anticancer compounds. Over 60%
anticancer agents currently used are derived from natural
sources, including plants, marine organisms, and micro-
organisms
33 and they offer an opportunity to study the
molecular mechanisms of tumorigenesis.
34
Considerable attention is currently focused on the
consumption of functional foods for the protection of
human health. In particular, there is intense interest in the
role of dietary antioxidants, which are capable of scaven-
ging the oxidants and free radicals responsible for initiating
various diseases.
35 Systematic investigations of the antiox-
idant properties of various foods, beverages, spices, and
herbs have been performed
36 and the number of papers
addressing the health-protective and antioxidant character-
istics of honey is increasing. Honey has been used as a
Figure 1 - Effect of honey on cell viability of PC-3 cells. Cells were treated with different concentrations of honey for 24, 48, and 72
hours. Viability was quantitated by MTT assay. Results are mean ¡ SEM. *** indicates p,0.001 at different time points compared to
controls.
Table 1 - Doses of honey extract that inhibited cell
growth by 50% (IC50) in the prostate cancer cell line PC-3.
IC50
72 h
24 h 48 h
PC-3 9.4¡0.02 (%) 1.7¡0.03 (%)
1.35¡0.05 (%)
Cells were treated with different concentrations of honey for 24, 48, and
72 hours. Viability was quantitated by MTT assay.
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1075natural source of sugars for a long time, as well as an
important ingredient in traditional medicine due to its
antimicrobial and anti-inflammatory properties.
37 The
health-protective and therapeutic effects of honey has been
attributed to the presence of various antioxidant compo-
nents, such as flavonoids, phenolic acids, organic acids,
enzymes, and vitamins,
38,39 while the main sugar constitu-
ents of honey, i.e., glucose and fructose, are either inhibitors
or accelerators of mutagenic activity.
40
Caffeic acid (3,4-dihydroxycinnamic acid) ester deriva-
tives, which are present in honey at levels of 20-25%, are
thought to exhibit a broad spectrum of activities that include
tumor inhibition.
41 The mechanism of the antitumor effect
shown in this study is unclear. It may be related to the
inhibitory effect of caffeic acid esters and flavonoid glycones
on tyrosine protein kinase (TPK), lipoxygenase, and
cyclooxygenase pathway metabolites. Several cellular com-
ponents associated with cell proliferation, such as poly-
amines and polyamine synthetic enzymes including
ornithine decarboxylase, are present at high levels in normal
and neoplastic cells. In addition, many kinases, such as TPK,
mediate proliferative as well as metabolic signals in cells.
Eicosanoids, the metabolites of arachidonic acid from the
lipoxygenase and cyclooxygenase pathways, exert a variety
of biological activities. Honey also contains various poly-
phones that have significant antiproliferative effects on
various cancer cells in vitro.
41 The apoptosis-inducing
potential of honey could be attributed to its phenolic
constituents. Various signaling pathways, including stimu-
lation of TNF-alpha (tumor necrosis factor-alpha) release,
inhibition of cell proliferation, induction of apoptosis and
cell cycle arrest, as well as inhibition of lipoprotein
oxidation, mediate the beneficial effects exerted by honey
and its major components, such as chrysin and other
flavonoids.
42
Flavonoids are a diverse family of natural phenolic
compounds commonly found in fruits, vegetables, and
honey. Flavonoids are generally safe and are associated with
low toxicity, making them ideal candidates for cancer
chemopreventive agents. Chrysin (5,7-dihydroxyflavone) is
a natural flavonoid present in honey. Recently, a number of
studies have shown that chrysin has multiple biological
activities, such as anti-inflammatory, anti-oxidant, and anti-
cancer effects.
43 In our study, we found chrysin induced
cytotoxicity and apoptosis in a prostate cancer cell line.
Chrysin has also been shown to inhibit tumor angiogenesis
in vivo, which is a key step in metastasis.
44 Chrysin may
inhibit chymotrypsin-like and trypsin-like proteasomes,
which play an important role in regulating apoptosis and
the cell cycle.
45 Chrysin suppresses expression of HIF-1a in
tumor cells in vitro and inhibits tumor cell-induced
angiogenesis in vivo.
44 Furthermore, we have shown that
chrysin induces cell cycle arrest and apoptosis in a prostate
cancer cell line. Li et al. attempted to further address the
anti-cancer potential of chrysin by assessing the sensitiza-
tion effect of chrysin on TNFa-mediated apoptotic cell death
and the molecular mechanisms involved.
46 Such sensitiza-
tion is closely associated with its inhibitory effect on NF-kB
activation, which in turn leads to reduced expression of the
anti-apoptotic NFkB target gene, c-FLIP-L, one of the key
anti-apoptotic genes capable of blocking caspase-8 activity.
Their reveal a novel function of chrysin and enhance the
value of chrysin as a useful anti-cancer agent. In addition,
the sensitization effect of chrysin on TNFa-induced cell
death is mainly achieved through enhanced activation of
Figure 2 - Effect of chrysin on cell viability of PC-3 cells. Cells were treated with different concentrations of chrysin for 24, 48, and 72
hours. Viability was quantitated by MTT assay. Results are mean ¡ SEM. * indicates p,0.05 and *** p,0.001 at different time points
compared to controls.
Table 2 - Doses of chrysin that inhibited cell growth by
50% (IC50) in the prostate cancer cell line PC-3.
IC50 48 h
72 h
PC-3 24.5¡0.08 mM
8.5¡0.01 mM
Cells were treated with different concentrations of chrysin for 24, 48, and
72 hours. Viability was quantitated by MTT assay.
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1076Figure 3 - Cytotoxic effects of chrysin on cell viability of PC-3 cells. Morphological changes of cells after treatment with different
concentrations of chrysin 48 hours post-treatment. A) Normal cells; B) 10 mM; and C) 40 mM.
Figure 4 - Assessment of apoptosis by Annexin V/PI on human prostate cancer cells (PC-3). The cells were treated with 10 and 40 mM
chrysin for 48 h (symbol P, PI) or media only (control symbol I), and apoptosis was examined by flow cytometry after Annexin V-PI
double staining. Necrotic cells lose membrane integrity, permitting PI entry. Viable cells exhibit Annexin V (-)/PI (-); early apoptotic cells
exhibit Annexin (+)/PI (-); late apoptotic cells or necrotic cells exhibit Annexin V (+)/PI (+).
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1077caspase 8, the initial caspase in the death receptor signaling
pathway that typically induces apoptosis.
46 NF-kB, one of
the main molecular targets of chemopreventive phytochem-
icals,
47 is a transcription factor involved in multiple cellular
processes, including apoptosis. Chrysin also induces apop-
tosis in association with activation of caspase-3, which
involves the inactivation of Akt or Protein kinase B (PKB)
signaling and down-regulation of X-linked inhibitor of
apoptosis protein (XIAP). Other studies have shown that
chrysin can potentiate the cytotoxicity of anti-cancer drugs
by depleting cellular GSH (glutathione), an important factor
in anti-oxidant defense.
48 Chrysin potentially induces p38,
activating NFkB/p65 in HeLa cells.
49 The MAPK p38
pathway has been implicated in the regulation of a wide
spectrum of cellular processes, including cell-cycle arrest
and apoptosis. Chrysin and other flavonoids extracted from
Scutellaria plants (apigenin, baicalein, baicalin, scutellarein,
and wogonin) showed dose-dependent inhibition of U87-
MG proliferation.
While our data shows that both honey and chrysin induce
cytotoxicity and apoptosis in a prostate cancer cell line,
honey is more potent. It seems that the variety of
polyphenols in honey may have stronger anti-proliferative
effects than chrysin alone. This is the first report on honey-
induced and chrysin-induced cytotoxicity and apoptosis in
human prostate cancer cells. Our data confirm that honey
has cytotoxic activity against human prostate cancer cells,
which is consistent with previous studies that indicate that
honey and its ingredients possess antitumor and antic-
arcinogenic properties. The ability to induce tumor cell
apoptosis is an important property in an anticancer drug
that discriminates it from a toxic compound.
50
Our study showed that honey and chrysin significantly
inhibit proliferation in PC-3 cells in a dose-dependent
manner (Fig. 1 and Fig. 2). Apoptosis induced by chrysin
was confirmed by Annexin V-FITC (Fig. 4). In the present
study chrysin-induced apoptosis was involved in cell death.
Apoptosis plays an essential role in the development and
maintenance of homeostasis and protection against viral
infection.
51 Apoptosis is characterized by distinct morpho-
logical features, including chromatic condensation, cell and
nuclear shrinkage, membrane blebbing, and oligo nucleo-
somal DNA fragmentation.
52 We found that honey contains
bioactive compounds that inhibit the proliferation of a
human prostate cell line (PC-3) through induction of
apoptosis or programmed cell death. Our results also
suggest that the anti-proliferative effects of honey are
mainly due to chrysin. Chrysin may therefore be considered
a potential compound for both cancer prevention and
treatment.
Our results provide important insight into the molecular
mechanisms involved in the anti-cancer activity of chrysin.
Although further studies are needed to fully elucidate the
mechanism involved in cell death, honey and chrysin are
promising chemotherapeutic agents in prostate cancer
treatment.
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